Advertisement

Most Recent

image: A Tree  Takes Root

A Tree Takes Root

By | April 1, 2016

Four apparently unrelated individuals share a common ancestor from whom they inherited a rare mutation that predisposed them to the cancer they share.

0 Comments

image: Death in the Dust

Death in the Dust

By | April 1, 2016

Follow Michele Carbone as he tracks down the genetic and environmental drivers of mesothelioma and other cancers.

1 Comment

image: Guts and Glory

Guts and Glory

By | April 1, 2016

An open mind and collaborative spirit have taken Hans Clevers on a journey from medicine to developmental biology, gastroenterology, cancer, and stem cells.

1 Comment

image: Pulling It All Together

Pulling It All Together

By | April 1, 2016

Systems-biology approaches offer new strategies for finding hard-to-identify drug targets for cancer.

0 Comments

image: Immune Influence

Immune Influence

By | April 1, 2016

In recent years, research has demonstrated that microbes living in and on the mammalian body can affect cancer risk, as well as responses to cancer treatment.

0 Comments

image: Microbes Meet Cancer

Microbes Meet Cancer

By | April 1, 2016

Understanding cancer’s relationship with the human microbiome could transform immune-modulating therapies.

4 Comments

image: Startup Licenses “Vaginal Seeding” Approach

Startup Licenses “Vaginal Seeding” Approach

By | March 31, 2016

Boston-based Commense plans to develop microbial and nonmicrobial interventions aimed at improving child health.

0 Comments

image: Minimal Genome Created

Minimal Genome Created

By | March 24, 2016

Scientists build a living cellular organism with a genome smaller than any known in nature.

3 Comments

image: Contacts May Affect Eye Microbiome

Contacts May Affect Eye Microbiome

By | March 23, 2016

The bacterial communities in the eyes of contact lens wearers resemble those of the skin, according to a study. 

0 Comments

Their $1.5 billion bid, which topped Thermo Fisher Scientific’s $1.3 billion offer for the genetic analysis company, was rejected.

0 Comments

Advertisement
Lonza Group
Lonza Group

Popular Now

  1. Antibody Maker Loses License Over Animal Welfare Violations
  2. ORI: Researcher Faked Dozens of Experiments
    The Nutshell ORI: Researcher Faked Dozens of Experiments

    A former scientist at the University of Michigan and the University of Chicago made up more than 70 experiments on heart cells, according to the Office of Research Integrity.

  3. Exploring Emotional Contagion
  4. Amyloid Thwarts Microbial Invaders
    Daily News Amyloid Thwarts Microbial Invaders

    Alzheimer’s disease–associated amyloid-β peptides trap microbes in the brains of mice and in the guts of nematodes, a study shows. 

Advertisement
Vergent Bio
Vergent Bio
Advertisement
Biosearch Technologies
illumina Corporate
illumina Corporate